Diabetes is one of the most important global health concerns of modern times. The causes of type 2 diabetes are multi-factorial and include both genetic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, and pancreas) insulin sensitivity. Many factors have been advised as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of Type 2 Diabetes. Many individuals suffering from type 2 diabetes are obese, with central visceral adiposity. With regards to the International Diabetes Federation, diabetes statistics says that there are more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. Patients with this disease cannot use glucose properly for their body needs. Latest research on Diabetes has led to the better living of the diabetic patients. In addition to this, self-monitoring of Blood glucose levels, lifestyle modifications and health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also add considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.

• Track 2-1: Beta cell and Aging
• Track 2-2: Aspects of non-beta cells in Glucose Homeostasis
• Track 2-3: Aspects of DNA Methylation in Insulin Secretion
• Track 2-4: Genetic Defects in Insulin Action

Diabetes depicts a gathering of metabolic maladies in which the individual has high blood glucose (blood sugar), it is either on the grounds that insulin creation is insufficient, or in light of the fact that the body's phones don't react appropriately to insulin, or both the sorts. The correct reason for sort 1 diabetes is obscure. What is known is that your invulnerable framework assaults and obliterates insulin-creating cells in the pancreas. This abandons you with almost no insulin. Rather than being transported into your cells, sugar develops in your circulation system. Sort 1 is thought to be brought on by a mix of hereditary helplessness and natural elements, however precisely what a large portion of those variables are as yet indistinct. In prediabetes — which can prompt type 2 diabetes — and in type 2 diabetes, your cells wind up plainly impervious to the activity of insulin, and your pancreas can't make enough insulin to conquer this resistance. Rather than moving into your cells where it's required for vitality, sugar develops in your circulatory system.

• Track 3-1: Genetics of Metabolic Syndrome
• Track 3-2: Upcoming Advances in Genetics of Diabetes
• Track 3-3: Diabetes in Specific Ethnic Groups
• Track 3-4: Genetic-lifestyle Interactions in the Prevention of Diabetes
• Track 3-5: Understanding the Genetics of Diabetes

Novel therapeutic mark available for diabetes includes Incretin based therapies, oral therapeutic agents likes secretagogues, beta cell regeneration & proliferation and stem cell therapies.  Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Aside from the above, various computational approaches in Diabetes management have been introduced recently with latest diabetes clinical trial going on which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These actions are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction combating the complications of diabetes like Gestational Diabetes, Diabetes Myopathy, Diabetes cardiopathy and more.

• Track 4-1: Novel Models in Diabetic Complications
• Track 4-2: Clinical Diagnosis and Laboratory Views
• Track 4-3: Polycystic Ovary Syndrome
• Track 4-4: Diagnostic Approaches
• Track 4-5: Clinical Trials on Animal Models
• Track 4-6: Novel Research and Treatment Specializations on Diabetes
• Track 4-7: Clinical Presentation and Diagnosis of Diabetes Mellitus in Adults

The universal diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes cure products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems which eliminates the risk of reverse diabetes. According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry achieved $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.

• Track 5-1: Diabetes Medications, TZDs, and Combinations
• Track 5-2: Better Second-Line Agent after Metformin: DPP-4 Inhibitors or SGLT-2 Inhibitors
• Track 5-3: MODY and its Types
• Track 5-4: Overviewing the Benefits and Risks of Diabetes Drugs
• Track 5-5: Metabolic Syndrome Genetics
• Track 5-6: Second- and Third-Line Pharmacotherapy for Type 2 Diabetes
• Track 5-7: Control of Disease

Cell therapy is characterized as the administration of live whole cells or maturation of a specific cell population in a patient for the treatment of a disease. Cell therapy is expanding its repertoire of cell types for administration. Cell therapy treatment strategies include isolation and transfer of specific stem cell populations, administration of effector cells, and induction of mature cells to become pluripotent cells, and reprogramming of mature cells. The establishment of pluripotent human embryonic stem cells and embryonic germ cells has introduced a new potential source for cell therapy in type 1 diabetic patients, especially in light of recent successes in producing glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

• Track 6-1: Cure for Type 1 Diabetes Stem Cells
• Track 6-2: Embryonic stem Cell Therapy
• Track 6-3: Embryonic stem Cell Therapy for Diabetes and its Complications
• Track 6-4: Beta Cells in Type 1 Diabetes
• Track 6-5: Mechanisms of Pancreatic β-Cell in Type 1 and Type 2 Diabetes
• Track 6-6: Diabetes Stem Cell

Obesity is a therapeutic condition in which abundance muscle to fat ratio has collected to the degree that it might negatively affect health. Individuals are by and large thought to be hefty when their body mass index (BMI), an estimation got by isolating a man's weight by the square of the individual's stature, is more than 30 kg/m2, with the range 25– 30 kg/m2 characterized as overweight. Some East Asian nations utilize bring down qualities. Obesity improves the probability of different diseases and conditions, especially it may cause

1. Cardiovascular diseases,
2. Type 2Diabetes,
3. Obstructive sleep apnea, certain types of disease,
4. Osteoarthritis and depression

• Track 7-1: Mortality
• Track 7-2: Obesity and Overweight
• Track 7-3: Morbidity
• Track 7-4: Obesity Causes
• Track 7-5: Lipid and Glucose Metabolism
• Track 7-6: Anabolic Steroids
• Track 7-7: Exogeneous Obesity
• Track 7-8: Genetic Susceptibility
• Track 7-9: Dietary Effects
• Track 7-10: Obesity and Rsk of Chronic Diseases Development
• Track 7-11: Hypertension
• Track 7-12: Hypothyroidism

Obesity and diabetes are Inter related diseases. As indicated by insights of Centre for Disease Control, the general population who were determined to have type II diabetes, 80-90% were analyzed as obese. For every 3 seconds, one individual is determined to have diabetes. Type II diabetes is a deep-rooted endless sickness in which elevated amounts of sugar (glucose) in the blood and the cells ignore the insulin. Type II diabetes Weight pickup is regular in individuals who take insulin to treat diabetes. That is a result of more insulin we use to maintain our blood glucose level, the more glucose is ingested into our cells, contrast with and by our body. The absorbed glucose was put away as a fat, which makes us gain weight.

• Track 8-1: Epidemic of Obesity and Diabetes
• Track 8-2: Genomics, Type 2 Diabetes, and Obesity
• Track 8-3: Association between Obesity and T2D
• Track 8-4: Adipocytokines in the Development of Obesity-related T2D
• Track 8-5: Anti-Obesity Drugs
• Track 8-6: Childhood Obesity and Effects
• Track 8-7: Pediatric Nutrition
• Track 8-8: Childhood Obesity Prevention
• Track 8-9: Childhood Obesity Prevention
• Track 8-10: Healthy Eating
• Track 8-11: Nutritional Science
• Track 8-12: Malnutrition
• Track 8-13: Clinical Nutrition

Obesity is associated with a few endocrine illnesses, including basic ones, for example, hypothyroidism and polycystic ovarian syndrome to rare ones, for example, Cushing's syndrome, central hypothyroidism, and hypothalamic disorders. The mechanisms for the improvement of weight shift in as per the endocrine condition. Hypothyroidism is associated with aggregation of hyaluronic acid inside different tissues, extra liquid maintenance because of decreased cardiovascular yield and reduces thermogenesis. The pathophysiology of obesity-related with polycystic ovarian syndrome stays unpredictable as obesity itself may simultaneously be the cause and the effect of the syndrome. The net abundance of androgen gives off an impression of being urgent in the advancement of central obesity. In Cushing's syndrome, an association with thyroid and development hormones plays an important part to an increased adipocyte separation and adipogenesis. This audit additionally depicts staying abnormal cases: hypothalamic obesity because of central hypothyroidism and combined hormone deficiencies

• Track 9-1: Endocrinology
• Track 9-2: Neuro Endocrinology
• Track 9-3: Pediatric Obesity
• Track 9-4: Current advances in Endocrinology Metabolism
• Track 9-5: Classical Endocrine Diseases causing Obesity
• Track 9-6: Obesity on Leptin
• Track 9-7: Obesity on Growth Hormones
• Track 9-8: Osteoporosis
• Track 9-9: Adrenal and Pituitary Tumors
• Track 9-10: Paediatric Endocrinology
• Track 9-11: Endocrine Regulation
• Track 9-12: Management of Obesity

Gynecology & Obstetrics is the branch of medicine managing the organization of administration to women, particularly the analysis and treatment of disorders affecting the female reproductive organs.it manages the investigation of diseases of the female reproductive organs, including the breasts. It is a branch of prescription that deals with the birth of kids and with the care of ladies before, during, after, they bring forth kids. The craftsmanship and art of overseeing pregnancy, labor, and the puerperium i.e. the time after delivery.

• Track 10-1: Gynecology and Obstetrics
• Track 10-2: Lack of Sleep
• Track 10-3: Ovarian Cysts
• Track 10-4: Gynoid Obesity
• Track 10-5: Macrosomia
• Track 10-6: Premature Birth
• Track 10-7: Overdue Pregnancy
• Track 10-8: Gestational Diabetes
• Track 10-9: Obesity and Infertility
• Track 10-10: Polycystic Ovarian Syndrome
• Track 10-11: Genetics of Obesity

The endocrine system is a grid of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a basic role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.

• Track 11-1: Gynecological Endocrinology Adrenal Disorders
• Track 11-2: Reproductive Endocrinology
• Track 11-3: Pediatric Endocrinology
• Track 11-4: Neuroendocrinology
• Track 11-5: Thyroid System Disorders
• Track 11-6: Pituitary Disorders
• Track 11-7: Pancreas Disorders
• Track 11-8: Metabolic Disorders
• Track 11-9: Osteoporosis
• Track 11-10: Podiatry
• Track 11-11: Other Hormonally-Related Conditions

The endocrine system is a network of glands that produce hormones and send them around the body through the blood. There are several glands in the system including the:

• Pituitary gland (which sits just under the brain)
• Thyroid gland (which sits in the front of the neck)
• Pancreas (which sits well above the tummy button in the abdomen)
• Parathyroid glands (which sit just behind the thyroid gland)
• Adrenal glands (which lie on top of the kidneys in the abdomen).

Endocrine cancer is cancer that begins in one of these glands. The most common sort of endocrine cancer is thyroid cancer, which begins in the thyroid gland. There are also some types of pancreatic cancer (cancer in the pancreas) that are classified as endocrine tumors.

Some tumors that grow in an endocrine gland are favorable, which means they're not cancerous. For example, most pituitary tumors are favorable. However, benign tumors are often treated in the same way as cancerous tumors.

• Track 12-1: Endocrine Tumor
• Track 12-2: Neuroendocrine Cancer
• Track 12-3: Pancreatic Cancer
• Track 12-4: Thyroid Cancer
• Track 12-5: Papillary Thyroid Cancer
• Track 12-6: Follicular Thyroid Cancer
• Track 12-7: Anaplastic Thyroid Cancer
• Track 12-8: Medullary Thyroid Cancer
• Track 12-9: Prostate Cancer
• Track 12-10: Ovarian Cancer
• Track 12-11: Sexual Health Cancer
• Track 12-12: Breast Cancer
• Track 12-13: Mental Health and Disorders

Public health is defined as the science of protecting the safety and improving the health of communities through education, policy making and research for disease and injury prevention. The definition of public health is different for every person. Whether you like to crunch numbers, conduct laboratory or field research, formulate policy, or work directly with people to help improve their health, there is a place for you in the field of public health. Being a public health professional enables you to work around the world, address health problems of communities as a whole, and influence policies that affect the health of societies

• Track 13-1: Epidemiology
• Track 13-2: Healthcare
• Track 13-3: Primary Health Care
• Track 13-4: Nutritional Epidemiology
• Track 13-5: Adolescent Health
• Track 13-6: Social Determinants of Health
• Track 13-7: Nutritional Health
• Track 13-8: Healthcare-Associated Infections
• Track 13-9: Sexual and Reproductive Health
• Track 13-10: Public Health and Diet
• Track 13-11: Obesity and Public Health
• Track 13-12: Community Health
• Track 13-13: Occupational Safety and Health

The perfect causes of diabetes are still not fully understood, it is known that obesity features up the threat of developing different types of diabetes mellitus. For type 2 diabetes, this includes being overweight or obese (having a BMI of 30 or greater). In fact, obesity is concluded to account for 80-85% of the threat of type II diabetes development, while recent research suggests that obese people are up to 80 times more inclined to develop type II diabetes than those with a BMI of less than 22. Studies suggest that abdominal fat reasons for the fat cells to discharge pro-inflammatory chemicals, which can make the body less sensitive to the insulin it produces by hindering the functionality of insulin responsive cells and their ability to respond to insulin.

• Track 14-1: Inflammatory Response
• Track 14-2: Insulin Resistance
• Track 14-3: Interruption in Fat Metabolism
• Track 14-4: Physical activities and lifestyle
• Track 14-5: Diet plan and Nutritional implications
• Track 14-6: Hemodialysis and Diabetes Nutrition

The risk factors for type 1 diabetes are still being researched. However, having a family member with type 1 diabetes slightly increases the risk of developing the disease. Environmental factors and exposure to some viral infections have also been linked to the risk of developing type 1 diabetes. Several risk factors have been associated with type 2 diabetes and include, Overweight, Physical inactivity, Unhealthy diet.

• Track 15-1: Diseases of the Pancreas
• Track 15-2: Family History of Diabetes
• Track 15-3: Psychological Behaviour
• Track 15-4: Diabetic Medicine
• Track 15-5: Diabetic Nursing
• Track 15-6: Diabetic Drug Invasion

The exact causes of diabetes are still not fully understood, it is known that obesity features up the threat of developing different types of diabetes mellitus. For type 2 diabetes, this includes being overweight or obese (having a BMI of 30 or greater). In fact, obesity is believed to account for 80-85% of the threat of type II diabetes development, while recent research suggests that obese people are up to 80 times more inclined to develop type II diabetes than those with a BMI of less than 22. Studies suggest that abdominal fat reasons for the fat cells to discharge pro-inflammatory chemicals, which can make the body less sensitive to the insulin it produces by hindering the functionality of insulin responsive cells and their ability to respond to insulin

• Track 16-1: Carbohydrate Counting
• Track 16-2: The Glycemic Index
• Track 16-3: Micronutrients and Diabetes
• Track 16-4: Alcohol and Diabetes
• Track 16-5: Protein and Diabetes
• Track 16-6: Medical Nutrition Therapy
• Track 16-7: Pregnancy and Lactation with Diabetes
• Track 16-8: Inflammatory Response
• Track 16-9: Insulin Resistance
• Track 16-10: Interruption in Fat Metabolism
• Track 16-11: Physical Activities and Lifestyle
• Track 16-12: Diet plan and Nutritional Implications
• Track 16-13: Hemodialysis and Diabetes Nutrition

An estimated 7.8 percent of the U.S. population has diabetes, a chronic disorder affecting the body’s metabolism. The most common form is type 2 diabetes, affecting approximately 90–95 percent of those with the disease. Type 2 diabetes is most often associated with older age, obesity, a family history of diabetes, physical inactivity, and certain ethnicities (NDIC, 2008). In addition, new research has also improved our understanding of the genetic underpinnings of type 2 diabetes. The diagnosis of type 2 diabetes includes the identification of insulin resistance, or the body’s inability to process insulin, which ultimately results in a buildup of glucose in the body. In contrast to type 1 diabetes, the symptoms of type 2 diabetes develop slowly over time. Recent research focuses on preventing or delaying type 2 diabetes in at-risk populations and has revealed that lifestyle interventions and some medications can reduce the development of diabetes.

• Track 17-1: Clinical Trials to Prevent Disease
• Track 17-2: Test a New Drug
• Track 17-3: New Treatment for Diabetes
• Track 17-4: Trialnet
• Track 17-5: GRADE
• Track 17-6: RISE
• Track 17-7: FNIH Biomarkers
• Track 17-8: Diabetic Drug Market
• Track 17-9: Oral Glucose Lowering Treatment
• Track 17-10: Insulin and its Analogues
• Track 17-11: Different Drug for Diabetic Patients
• Track 17-12: Advanced Products
• Track 17-13: Telemedicine
• Track 17-14: Ayurvedic and Herbal Medicines

Diabetes is a common disease, yet every individual needs unique care. We encourage people with diabetes and their families to learn as much as possible about the latest medical therapies and approaches, as well as healthy lifestyle choices. Good communication with a team of experts can help you feel in control and respond to changing needs.

• Track 18-1: Diabetes in Specific Ethnic Groups
• Track 18-2: Gestational Diabetes
• Track 18-3: Pregnancy with Type 1 Diabetes
• Track 18-4: Risk factors for Type 2 Diabetes
• Track 18-5: Diabetic Neuropathy and Dietary Supplements
• Track 18-6: Novel Biomarkers for Type 2 Diabetes

Diabetes can be very complicated, as diabetes is a prime risk factor for cardiovascular disease, controlling other risk factors which may give rise to secondary conditions, as well as the diabetes itself, is one of the facets of diabetes management. Checking cholesterol, LDL, HDL and triglyceride levels may indicate hypolipoproteinemia, which may warrant treatment with hypolipidemic drugs. Checking the blood pressure and keeping it within strict limits (using diet and antihypertensive treatment) protects against the retinal, renal and cardiovascular complications of diabetes. Regular follow-up by foot health specialists is encouraged to prevent the development of diabetic foot. Annual eye exams are suggested to monitor for progression of diabetic retinopathy. Both Type 1 and 2 diabetics can see comic effects on their blood sugars through controlling their diet, and some Type 2 diabetics can fully control the disease by dietary modification.

• Track 19-1: Diabetic Meal Plan
• Track 19-2: Macrovascular Complications: Coronary Artery Diseases, Cardiomyopathy, and Stroke
• Track 19-3: Diabetic Mastopathy
• Track 19-4: Wound Therapy for Management of Diabetic Foot
• Track 19-5: Diabetes and Parkinson
• Track 19-6: Diabetic Dyslipidemia
• Track 19-7: Diabetic Ketoacidosis
• Track 19-8: Diabetic Nephropathy
• Track 19-9: Diabetes Retinopathy
• Track 19-10: Diabetic foot: Care and Management
• Track 19-11: Impact of Physical Activity & Yoga Therapy
• Track 19-12: Control Blood Glucose Levels by Personalized Nutrition
• Track 19-13: Lifestyle and Eating Habits Relate to Diabetes

The risk factors for type 1 diabetes are still being researched. However, having a family member with type 1 diabetes slightly increases the risk of developing the disease. Environmental factors and exposure to some viral infections have also been linked to the risk of developing type 1 diabetes. Several risk factors have been associated with type 2 diabetes and include, Overweight, Physical inactivity, Unhealthy diet

• Track 20-1: Family History of Diabetes
• Track 20-2: Diseases of the Pancreas
• Track 20-3: Smoking
• Track 20-4: Fat Distribution
• Track 20-5: Overweight
• Track 20-6: Abnormal Cholesterol and Triglyceride Levels
• Track 20-7: Physical Inactivity
• Track 20-8: Obesity & Diabetes